The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres
Open accessAbstract
Polymeric microspheres have gained widespread application as drug eluting depots. Typically, drug-loaded polymeric microspheres are prepared by oil-in-water emulsification which yields a product with a broad size distribution. The aim of the present study was to investigate the properties of different size-fractions of drug-loaded microspheres, in order to delineate whether particle size governs drug loading efficiency and release profile. Gefitinib-loaded PLGA-based microspheres were prepared using an oil-in-water solvent evaporation method and wet-sieved to obtain well-defined size fractions of 5 ± 1, 32 ± 4, 70 ± 3, and 130 ± 7 μm, respectively. The average drug loading of unfractionated microspheres was 6.3 ± 0.4% w/w, while drug loading of sieved fractions ranged from 2.4 ± 0.3 to 7.6 ± 0.9% w/w for smallest to largest microparticles. X-ray diffraction (XRD) and differential scanning calorimetry (DSC) analysis demonstrated that gefitinib was amorphously dispersed in the PLGA matrix, with no apparent shift in the T g of PLGA indicating the absence of direct molecular interactions of the drug and polymer due to the formation of small drug particles embedded in PLGA. In vitro drug release was studied with microspheres embedded in dextran hydrogels to avoid their aggregation during the incubation conditions. Microspheres smaller than 50 μm showed rapid diffusion-based release reaching completion within 2 days when particles have not degraded yet. Larger microspheres, however, showed a sigmoidal release pattern that continued for three months in which diffusion (early stage) as well as particle erosion (later stage) governed drug release. Scanning electron microscopy (SEM) and polymer degradation data showed that larger microspheres degraded faster than smaller ones, which is in line with autocatalytic PLGA degradation upon acidification within the core of microparticles. In conclusion, we showed that different size-fractions of drug-loaded microspheres showed quite distinct drug loading and release kinetics. Control of microparticle size by fractionation is therefore an important determinant for obtaining well-defined and reproducible sustained release depots.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modeling and comparison of dissolution profiles
Costa, P., & Sousa Lobo, J. M. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00095-1 · Cited by 5,509 · cited 1×
“Although mechanistic models for drug-eluting depots such as the Higuchi model or the Korsmeyer − Peppas model have been used to describe drug release pro fi les from microspheres, 20 − 22 most release pro fi les are best described by nonmechanistic sigmoidal curve fi tting models.”
Biodegradation and biocompatibility of PLA and PLGA microspheres
Anderson, J. M., & Shive, M. S. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00048-3 · Cited by 2,617
Modeling of diffusion controlled drug delivery
Siepmann, J., & Siepmann, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.006 · Cited by 935
Freitas, S., Merkle, H. P., & Gander, B. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.015 · Cited by 923
Preparation of microspheres by the solvent evaporation technique
O'Donnell, P. B., & McGinity, J. W. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00049-5 · Cited by 806
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
Wischke, C., & Schwendeman, S. P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.042 · Cited by 790
Mathematical modeling of bioerodible, polymeric drug delivery systems
Siepmann, J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00116-8 · Cited by 772
Management of non-small-cell lung cancer: recent developments
Reck, M., Heigener, D. F., Mok, T., Soria, J.-C., & Rabe, K. F. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61502-0 · Cited by 714
Particle control of emulsion by membrane emulsification and its applications
Nakashima, T., Shimizu, M., & Kukizaki, M. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00099-5 · Cited by 406
Precise control of PLG microsphere size provides enhanced control of drug release rate
Berkland, C., King, M., Cox, A., Kim, K. (., & Pack, D. W. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00136-0 · Cited by 400
Cited by
Hydrogel microparticles for biomedical applications
Daly, A. C., Riley, L., Segura, T., & Burdick, J. A. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0148-6 · Cited by 1,249
Advanced drug delivery systems and artificial skin grafts for skin wound healing
Kim, H. S., Sun, X., Lee, J.-H., Kim, H.-W., Fu, X., & Leong, K. W. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.12.014 · Cited by 625
Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles
Yoo, J., & Won, Y.-Y. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01228 · Cited by 392
Zero-order drug delivery: State of the art and future prospects
Laracuente, M.-L., Yu, M. H., & McHugh, K. J. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.020 · Cited by 384
Functionalizing PLGA and PLGA Derivatives for Drug Delivery and Tissue Regeneration Applications
Martins, C., Sousa, F., Araújo, F., & Sarmento, B. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701035 · Cited by 362
Vlachopoulos, A., Karlioti, G., Balla, E., Daniilidis, V., Kalamas, T., Stefanidou, M., Bikiaris, N. D., Christodoulou, E., Koumentakou, I., Karavas, E., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020359 · Cited by 277
Polymeric drug delivery systems by additive manufacturing
Borandeh, S., van Bochove, B., Teotia, A., & Seppälä, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.022 · Cited by 254
Metadata
- Authors
- Chen, W., Palazzo, A., Hennink, W. E., & Kok, R. J.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-12-27
- Volume
- 14
- Issue
- 2
- Pages
- 459-467
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W2566626029
- Cited by
- 262
- References
- 35
- FWCI
- 7.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.